Commodity Channel Index
|Bid||124.64 x 900|
|Ask||129.07 x 900|
|Day's Range||127.70 - 132.18|
|52 Week Range||81.79 - 169.14|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||133.89|
|Earnings Date||Apr 27, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||149.18|
IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced the launch of its COVID Active Research Experience (CARE) Project at helpstopcovid19.com. The IQVIA CARE Project is an opt-in registry available to anyone – to advance understanding of COVID-19 through shared information about disease prevalence, symptom progression, and treatment outcomes.
IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced its new technology-enabled COVID-19 Trial Matching Tool at c19trials.com, which is one of the world’s first online platforms that matches individuals with specific COVID-19 studies to accelerate clinical research projects.
One of the Triangle's largest contract research organizations (CRO) has updated its previous guidance regarding the impact of COVID-19, saying it will cost the company millions more than expected.
IQVIA Holdings (IQV) witnesses global site closures and disruptions in operations, which require face-to-face dealings, in the wake of coronavirus outbreak.
ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.
IQVIA provides update on business conditions in light of COVID-19 and provides revised first-quarter 2020 guidance; releases Q1 earnings April 28th
Over the first quarter of 2020, more than $31 billion in value disappeared from the books of local public companies that collectively employ more than a hundred thousand workers in the Triangle and across the U.S.
Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its collaboration with the University of Texas Medical Branch (UTMB) to develop a novel assay for COVID-19 (SARS-CoV-2) tests, an essential tool for rapid development of a Coronavirus vaccine. Once a viable assay is developed, Q2 Solutions labs will produce it for use in clinical trials to determine the effectiveness of a COVID-19 vaccine.
Moody's Investors Service ("Moody's") assigned a Ba1 rating to a new senior secured term loan A issued by IQVIA Inc. (collectively, "IQVIA"). For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of IQVIA Inc. New York, March 09, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of IQVIA Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
It could develop into a serious long-term problem for the pharmaceutical industry, which relies on clinical trials to get new drugs to the market.
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
Global concerns over the spread of the novel coronavirus rocked stock markets on Monday. The spread of COVID-19 has been a major economic punch felt around the globe, and it's impacting production at Triangle firms – from Lenovo to Cree.
One of Raleigh and Durham's more prominent subsets in its burgeoning life sciences is contract research. And this area has become a hotbed for those companies and the workers they attract. The CRO industry is the subject of one of Triangle Business Journal’s lists this week.
Ari Bousbib has been the CEO of IQVIA Holdings Inc. (NYSE:IQV) since 2016. First, this article will compare CEO...
One of the Triangle's premier contact research giants says it expects the blockbuster success of 2019 to carry into 2020.
IQVIA (IQV) delivered earnings and revenue surprises of 1.16% and 1.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?